EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Homebiogas Ltd (HMGS) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of Homebiogas Ltd ILS 0.14, price ILS 0.86, upside -83.2%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Utilities · Il · ISIN IL0011722043

HL Thin data Oct 4, 2026

Homebiogas Ltd

HMGS · TA

Weakest SetupStrongly overvalued and low quality.

Low debt
Quality 42/100
Fair value 0.1445 ILA · Strongly overvalued (−83.2%)
Weak Growth (revenue 5y +25.2 %/yr in USD)
Loss-making · -169.0% net margin (TTM)
Negative free cash flow
Trails peers (2/10)
Narrow moat 10/100
Thin data
⚠ Dilution

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

13.11 ILA 0.4590 ILA Fair Value 0.1445 ILA Jun 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.

How to read this chart

60‑month range 0.4590 ILA – 13.11 ILA · fair‑value band 0.0935 ILA – 0.1785 ILA · the 0.8600 ILA price screens above the 0.1445 ILA fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 4, 2026.

Follow Homebiogas in your weekly email

Every Wednesday you see whether Homebiogas is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

HomeBiogas Ltd develops, produces, and markets biogas systems for the treatment of organic waste into clean energy for homeowners, farmers, education centers, and community gardens in Israel, Australia, Rwanda, Paraguay, the United States of America, England, and internationally.

Show more

HomeBiogas Ltd develops, produces, and markets biogas systems for the treatment of organic waste into clean energy for homeowners, farmers, education centers, and community gardens in Israel, Australia, Rwanda, Paraguay, the United States of America, England, and internationally. The company offers HomeBiogas 2, a bio-digester that converts kitchen waste into clean cooking gas and liquid bio-fertilizer; HomeBiogas 4, a bio-digester that converts kitchen waste to gas and fertilizer for larger households; HomeBiogas 2 + Toilet, a eco-friendly toilet that converts waste into clean energy; and HomeBiogas 4 + 2 Toilets, a dual-unit bio-toilet for larger households. It also provides additional products, such as annual maintenance kits, annual service kits for old bio-toilets, and countertop biogas stoves. In addition, the company operates an online shop for its products. Its products provide solutions for food waste systems, bio-toilets, dairy farmer systems, and buying carbon. HomeBiogas Ltd was incorporated in 2012 and is headquartered in Beit Yanai, Israel.

Stock analysis

Homebiogas Ltd (HMGS) currently trades at 0.8600 ILA, while our model-based Fair Value estimate is 0.1445 ILA, 83.2% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 88/100, which puts the evidence level at low.

Scenario range: 0.0935 ILA (bear) to 0.1785 ILA (bull), the price of 0.8600 ILA sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Utilities sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Homebiogas Ltd reported revenue of $3.1M in FY2025 versus $2.5M in FY2021, a compound +5.9%/yr. Reported net income was −$4.1M in FY2025.

Key figures

Market cap 32.0M ILA · P/S ratio 8.20 · EPS (TTM) −0.5200 ILA · Net margin −132% · Return on equity −134% · Return on assets (EBIT) −67.7% · Operating margin −87.1% · Revenue (TTM) $3.0M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).

What moves the price

The share trades about 49% below its 52-week high and 87% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Utilities peers we cover trades at −40% fair-value upside, at −83%, HMGS screens richer than that median.

Fair Value models

Bear 0.0935 ILA Fair Value 0.1445 ILA Bull 0.1785 ILA
Price 0.8600 ILA · Upside -83.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 0.1500 ILA 0.2000 ILA 0.3000 ILA 54
All 1 models by family
Asset-Based
NCAV (Graham) 0.1500 ILA 0.2000 ILA 0.3000 ILA 54

Open the full fair value analysis →

Notify me when HMGS reaches fair value

Put HMGS on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 42/100

Of which business quality 42 · Market factors (momentum, volatility) 43

Profitability 14
Margins and returns on capital today
Quality Growth 96
Are margins and returns improving?
Cashflow 2
Earnings quality: real cash, not paper profit
Fin. Strength 70
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 55
Price trend over the last 3–12 months (market factor)
52W Momentum 17
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+18.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.2%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−386.7% (2020) → −132.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

HMGS screens overvalued: fair value 83% below the price. Compare with China Yangtze Power Co →

Compare Homebiogas Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Utilities - Renewable · 198 stocks

Beats the industry median on 1/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 42 · Below median
Fair Value upside −83.2% · Bottom 25%
Profitability
Return on assets −35.8% · Bottom 25%
Net margin (TTM) −169.0% · Bottom 25%
Operating margin (TTM) −87.1% · Bottom 25%
Growth and dividend
Revenue growth 9.1% · Above median

Valuation Multiplesvs Utilities - Renewable median · lower = cheaper

P/B 3.75× · Priciest 25%
P/S (TTM) 3.46× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 15
FUTURE (revenue growth)46 · sector 6
PAST (return on equity)0 · sector 13
HEALTH (low debt)100 · sector 68
DIVIDEND (yield)0 · sector 44

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Utilities - Renewable stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
China Yangtze Power Co 600900 ¥28.36 ¥31.20 +10%
Ørsted A/S ORSTED kr 139.45 kr 31.40 −77%
Huaneng Lancang River Hydropower Inc 600025 ¥9.75 ¥4.45 −54%
Fortum Oyj FORTUM €23.42 €14.06 −40%
Adani Green Energy Limited ADANIGREEN ₹1,297 ₹169.61 −87%
SDIC Power Holdings 600886 ¥14.86 ¥16.35 +10%
EDP Renewables, S.A EDPR €12.99 €3.53 −73%
China Three Gorges Renewables (Group) Co 600905 ¥3.61 ¥2.40 −34%
Public Power Corporation PPC €22.96 €7.44 −68%
GD Power Development Co 600795 ¥5.34 ¥5.99 +12%

Explore undervalued stocks

More undervalued Utilities stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Homebiogas Ltd Fair Value". https://www.fairvalue-calculator.com/stock/HMGS

Frequently asked questions

Is Homebiogas Ltd (HMGS) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of 0.1445 ILA versus a price of 0.8600 ILA, about −83% upside (overvalued).
What is the fair value of HMGS?
Our model-based fair value for Homebiogas Ltd is 0.1445 ILA (as of Oct 4, 2026), built from audited fundamentals. The current price: 0.8600 ILA.
What is the quality score of HMGS?
Homebiogas Ltd has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Homebiogas Ltd (HMGS)?
Our model-based price target is the fair value of 0.1445 ILA (as of Oct 4, 2026) from 1 valuation models. Cautious scenario 0.0935 ILA, optimistic scenario 0.1785 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Homebiogas Ltd stock forecast for 2026?
Our models put fair value at 0.1445 ILA, about −83% upside versus a price of 0.8600 ILA (overvalued). Cautious scenario 0.0935 ILA, optimistic scenario 0.1785 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of Homebiogas Ltd (HMGS)?
Homebiogas Ltd reported trailing-twelve-month revenue of about $3.0M (latest available figure, as of Oct 4, 2026).
What is the intrinsic value of Homebiogas Ltd (HMGS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Homebiogas Ltd it is 0.1445 ILA per share (as of Oct 4, 2026), against a price of 0.8600 ILA. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Homebiogas Ltd stock overvalued or undervalued in 2026?
As of Oct 4, 2026, HMGS trades above its calculated fair value: price 0.8600 ILA, fair value 0.1445 ILA, a gap of about −83% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HMGS?
No. The price is what the market pays today (0.8600 ILA); the fair value is what the company's own numbers justify (0.1445 ILA). For Homebiogas Ltd the two are 0.7155 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Homebiogas Ltd worth?
The market values Homebiogas Ltd at about 32.0M ILA (market capitalisation, as of Oct 4, 2026). Per share that is 0.8600 ILA; our models calculate a fair value of 0.1445 ILA per share.
What do the bullish and bearish scenarios say about HMGS?
Our models span a range for Homebiogas Ltd: cautious scenario 0.0935 ILA, base 0.1445 ILA, optimistic 0.1785 ILA per share (as of Oct 4, 2026, price 0.8600 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Homebiogas Ltd (HMGS)?
Balance-sheet figures for Homebiogas Ltd (as of Oct 4, 2026): return on equity −133.8%. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is HMGS from its 52-week high?
Homebiogas Ltd trades at 0.8600 ILA, about 49% below its 52-week high of 1.68 ILA and 87% above the low of 0.4590 ILA (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of 0.1445 ILA is for.
Which stocks are comparable to Homebiogas Ltd?
From the same area (Utilities) we also value China Yangtze Power Co, Ørsted A/S, Huaneng Lancang River Hydropower Inc, Fortum Oyj, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Homebiogas Ltd stock attractive at the current price?
The data as of Oct 4, 2026: price 0.8600 ILA, calculated fair value 0.1445 ILA (−83%), Quality Score 42/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HMGS calculated?
We run Homebiogas Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.1445 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Homebiogas Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Homebiogas Ltd (HMGS)?
The closing price on Oct 1, 2026 was 0.8600 ILA. Our model-based fair value is 0.1445 ILA, about −83% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Homebiogas Ltd right now?
The price sits above even our optimistic bull case (0.1785 ILA). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (0.0935 ILA to 0.1785 ILA) leaves room in how you read the outcome.

Key figures of Homebiogas Ltd

How large is the market capitalisation of Homebiogas Ltd (HMGS)?
The market capitalisation of Homebiogas Ltd is 32.0M ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Homebiogas Ltd (HMGS)?
The price-to-sales ratio of Homebiogas Ltd is 8.20 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Homebiogas Ltd (HMGS)?
Earnings per share at Homebiogas Ltd are −0.5200 ILA. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Homebiogas Ltd (HMGS)?
The net margin of Homebiogas Ltd is −132% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Homebiogas Ltd (HMGS)?
The return on equity (ROE) of Homebiogas Ltd is −134% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Homebiogas Ltd (HMGS)?
On an EBIT basis the return on assets of Homebiogas Ltd is −67.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Homebiogas Ltd (HMGS)?
The operating margin of Homebiogas Ltd is −87.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Homebiogas Ltd (HMGS)?
Revenue at Homebiogas Ltd is growing +9.1% versus a year earlier (3y avg −12.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Homebiogas Ltd (HMGS) generate?
The free cash flow of Homebiogas Ltd is −$2.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Homebiogas Ltd (HMGS) hold?
Homebiogas Ltd holds more cash than debt, $1.6M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Homebiogas Ltd in the live analysis

One click puts Homebiogas Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.